Author:
Qi Kang,Li Lujin,Li Xiangdong,Zhao Jinglin,Wang Yang,You Shijie,Hu Fenghuan,Zhang Haitao,Cheng Yutong,Kang Sheng,Cui Hehe,Duan Lian,Jin Chen,Zheng Qingshan,Yang Yuejin
Publisher
Public Library of Science (PLoS)
Reference62 articles.
1. The challenge of traditional Chinese medicines for allopathic practitioners;LD Karalliedde;Am J Physiol Heart Circ Physiol,2009
2. Traditional Chinese medication Tongxinluo dose-dependently enhances stability of vulnerable plaques: a comparison with a high-dose simvastatin therapy;L Zhang;Am J Physiol Heart Circ Physiol,2009
3. No-reflow protection and long-term efficacy for acute myocardial infarction with Tongxinluo: a randomized double-blind placebo-controlled multicenter clinical trial (ENLEAT Trial);HT Zhang;Chin Med J (Engl),2010
4. Tongxinluo reduces myocardial no-reflow and ischemia-reperfusion injury by stimulating the phosphorylation of eNOS via the PKA pathway;XD Li;Am J Physiol Heart Circ Physiol,2010
5. Protein kinase A-mediated cardioprotection of Tongxinluo relates to the inhibition of myocardial inflammation, apoptosis, and edema in reperfused swine hearts;XD Li;Chin Med J (Engl),2013
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献